The Barbie movie has sparked a marketing boom, but also renewed attention to women's issues, including health. (Photo by: KGC-138/STAR MAX/IPx)
August 1, 2023 01:11 PM EDTUpdated 02:54 PM
Pharma
Marketing

Can the Bar­bie movie's spot­light on women’s is­sues spill over to phar­ma mar­ket­ing and health­care? Agency says yes

Beth Snyder Bulik

Senior Editor

It’s a Bar­bie world late­ly, but could the pop­u­lar­i­ty of the sum­mer block­buster movie trans­late to re­al par­i­ty for women in ar­eas like health­care and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times